Pharvaris BV

Company Profile

Pharvaris BV had its IPO on 2021-02-05 under the ticker symbol PHVS.

The company operates in the Healthcare sector and Biotechnology industry. Pharvaris BV has a staff strength of 68 employees.

Stock update

Shares of Pharvaris BV opened at $19.64 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $19.25 - $20.27, and closed at $19.85.

This is a +1.28% increase from the previous day's closing price.

A total volume of 69,055 shares were traded at the close of the day’s session.

In the last one week, shares of Pharvaris BV have slipped by -6.89%.

Pharvaris BV's Key Ratios

Pharvaris BV has a market cap of $849.82 million, indicating a price to book ratio of 1.591 and a price to sales ratio of 0.

In the last 12-months Pharvaris BV’s revenue was $0 with a gross profit of $0 and an EBITDA of $-89486560. The EBITDA ratio measures Pharvaris BV's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Pharvaris BV’s operating margin was 0% while its return on assets stood at -28.21% with a return of equity of -50.62%.

In Q2, Pharvaris BV’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Pharvaris BV’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-2.68 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Pharvaris BV’s profitability.

Pharvaris BV stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -1.689. Its price to sales ratio in the trailing 12-months stood at 0.

Pharvaris BV stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$189.74 million

Total Liabilities

$15.90 million

Operating Cash Flow

$0

Capital Expenditure

$35076

Dividend Payout Ratio

0%

Pharvaris BV ended 2024 with $189.74 million in total assets and $0 in total liabilities. Its intangible assets were valued at $189.74 million while shareholder equity stood at $173.73 million.

Pharvaris BV ended 2024 with $0 in deferred long-term liabilities, $15.90 million in other current liabilities, 4898751.00 in common stock, $-208863367.00 in retained earnings and $0 in goodwill. Its cash balance stood at $179.19 million and cash and short-term investments were $179.19 million. The company’s total short-term debt was $228,120 while long-term debt stood at $0.

Pharvaris BV’s total current assets stands at $189.01 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $334299.00 compared to accounts payable of $4.65 million and inventory worth $8.53 million.

In 2024, Pharvaris BV's operating cash flow was $0 while its capital expenditure stood at $35076.

Comparatively, Pharvaris BV paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$19.85

52-Week High

$26.86

52-Week Low

$1.77

Analyst Target Price

$21.42

Pharvaris BV stock is currently trading at $19.85 per share. It touched a 52-week high of $26.86 and a 52-week low of $26.86. Analysts tracking the stock have a 12-month average target price of $21.42.

Its 50-day moving average was $17.94 and 200-day moving average was $11.06 The short ratio stood at 0.22 indicating a short percent outstanding of 0%.

Around 797.5% of the company’s stock are held by insiders while 7605.9% are held by institutions.